Inhalative nanomedicine--opportunities and challenges. - Wikidata - awgldk - TriplyDB

Inhalative nanomedicine--opportunities and challenges.

Inhalative nanomedicine--opportunities and challenges.

http://www.wikidata.org/entity/Q37532479

about

Imaging the paediatric lung: what does nanotechnology have to offer?Advances in device and formulation technologies for pulmonary drug delivery.In vitro and in vivo testing methods for respiratory drug delivery.Toxico-/biokinetics of nanomaterials.Nanoparticle-based therapy for respiratory diseases.The effects of engineered nanoparticles on pulmonary immune homeostasis.Nanodrugs: pharmacokinetics and safety.Pulmonary drug delivery: a review on nanocarriers for antibacterial chemotherapy.Biological voyage of solid lipid nanoparticles: a proficient carrier in nanomedicine.Health implications of engineered nanoparticles in infants and children.Polymeric nanoparticles in development for treatment of pulmonary infectious diseases.Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities Sertoli Cells Loaded with Doxorubicin in Lipid Micelles Reduced Tumor Burden and Dox-Induced Toxicity.A Potential Nanomedicine Consisting of Heparin-Loaded Polysaccharide Nanocarriers for the Treatment of Asthma Evaluating the Controlled Release Properties of Inhaled Nanoparticles Using Isolated, Perfused, and Ventilated Lung Models

P2860

Q26996739-54A5B25E-6F34-44F0-BF67-2F167DAC50CE Q33962567-5F9FCCFA-D42E-49BC-8FEA-B5F0C505A294 Q37822755-008771F0-3252-4616-8920-A5E768CF0A38 Q38009230-87212014-E49D-49A7-B094-5B2EFAFFD8C2 Q38086501-EFBB02B1-575B-48EA-A5AE-88C56DD5F97A Q38165210-7A43AC53-6794-42AD-85EE-1E35A76418AD Q38193067-65B15196-18DE-4D29-B40D-52E00E0025CE Q38552573-D0EA3FA4-DA27-4546-8BD8-5E30DE2AD87D Q38558905-5863C0F0-7BA9-46C8-BDA6-3AB0E68838EC Q38562639-4040B43B-FAF8-491A-AB78-3DE3B69C91F8 Q38789348-DBDA2728-148F-4287-90D9-90BC06B71CEB Q39306543-B5CF5101-12F2-4F3D-819E-92C5B117E5D5 Q47676301-91B144E8-5177-4C44-B5AB-BF994D322303 Q56992635-70AFF5B8-05C7-459D-B0D9-F839E3B8E6B6 Q58691546-F975EF39-477A-4A96-904E-600684F3486D

P2860

Inhalative nanomedicine--opportunities and challenges.

http://www.wikidata.org/entity/Q37532479

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Inhalative nanomedicine--opportunities and challenges.

@en

Inhalative nanomedicine--opportunities and challenges.

@nl

type

label

Inhalative nanomedicine--opportunities and challenges.

@en

Inhalative nanomedicine--opportunities and challenges.

@nl

prefLabel

Inhalative nanomedicine--opportunities and challenges.

@en

Inhalative nanomedicine--opportunities and challenges.

@nl

P1433

Q37532479-F9CF508F-4418-49A2-9F07-C1D4DDFD2920

P1476

Q37532479-13E01ED6-1FBE-4BC5-88E7-05E686087D22

P2093

Q37532479-05F49644-4032-4818-8F7D-6A93419C314B

Q37532479-088631D0-ABE7-4CC5-B298-4279DB30865C

Q37532479-B78C14E3-E6C0-4547-8596-706121EA3C4B

P2860

Q37532479-02A47177-0C29-4AC7-BF45-AD270A24AF34

Q37532479-200DCBC1-EF90-42B1-83E0-08133C654251

Q37532479-32C94AB4-CC74-4F6D-9711-973F15C1D643

Q37532479-3564AC22-2AD2-45A4-AE82-37B62DDF4FB1

Q37532479-3C1F7A57-45FD-416C-AF78-8C015B42FB5C

Q37532479-480CEED3-E4DC-48A4-B7B6-33C6A2F6403B

Q37532479-54554C8D-D33C-4FF8-A0EF-1F61502F5EB8

Q37532479-5516F6BC-A62D-4768-8F57-C31EBA7EC24E

Q37532479-5E4DA34C-C87D-4EB9-8890-BC98EBF6C0CB

Q37532479-6CB29617-5C47-4079-AC38-1F5229607453

P304

Q37532479-992B7B94-7F16-462C-92A4-4F778BCEAA2B

P31

Q37532479-C1CF8D5D-E453-4798-9722-7898C6F99B71

P356

Q37532479-14FBE8A2-494E-4C3D-9F96-D9884A897186

P478

Q37532479-0579C996-E9C8-438D-8694-6CA670357B49

P50

Q37532479-28159553-3A59-4E9E-AB5A-2CB21BB136E1

Q37532479-E3C3619B-744E-46E8-ACD0-06EEE4C20B47

P577

Q37532479-D78C21E1-E846-418D-8A8D-2BDD6C6D4251

P698

Q37532479-6C5EAD72-DC16-44E3-8175-7A38F8F5F921

P356

08958370902962283

P1433

Inhalation Toxicology

P1476

Inhalative nanomedicine--opportunities and challenges

@en

P2093

Andreas Henning

http://www.w3.org/2001/XMLSchema#string

Michael Bur

http://www.w3.org/2001/XMLSchema#string

Stephanie Hein

http://www.w3.org/2001/XMLSchema#string

P2860

Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells

Characterisation of xenobiotic-metabolising enzyme expression in human bronchial mucosa and peripheral lung tissues

Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts

Embryonic chicken trachea as a new in vitro model for the investigation of mucociliary particle clearance in the airways

Pulmonary absorption rate and bioavailability of drugs in vivo in rats: structure-absorption relationships and physicochemical profiling of inhaled drugs.

In vitro assessment of transferrin-conjugated liposomes as drug delivery systems for inhalation therapy of lung cancer.

The influence of chitosan content in cationic chitosan/PLGA nanoparticles on the delivery efficiency of antisense 2'-O-methyl-RNA directed against telomerase in lung cancer cells.

Clinical perspectives on pulmonary systemic and macromolecular delivery.

In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery.

Mucus quality on horse tracheal epithelium: microscopic grading based on transparency.

P304

137-143

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/08958370902962283

http://www.w3.org/2001/XMLSchema#string

P478

21 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P50

Claus-Michael Lehr

P577

2009-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19558246

http://www.w3.org/2001/XMLSchema#string